Organization
Lysogene
1 clinical trial
Clinical trial
An Open-Label Adaptive-Design Study of Intracisternal Adenoassociated Viral Vector Serotype rh.10 Carrying the Human β-Galactosidase cDNA for Treatment of GM1 GangliosidosisStatus: Terminated, Estimated PCD: 2023-05-22